Naoyuki Miura
Corporate Officer/Principal presso Daiwa Corporate Investment Co., Ltd.
Provenienza dei contatti di primo grado di Naoyuki Miura
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Daiwa Corporate Investment Co., Ltd.
Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment Co. Ltd. (Daiwa Corporate Investment) is a private equity arm of Daiwa Securities Group Inc. and is headquartered in Tokyo, Japan. The firm was founded in 1982.
29
| Subsidiary | Investment Managers | 29 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Naoyuki Miura tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
DAIWA SECURITIES GROUP INC. | Investment Banks/Brokers | Director of Finance/CFO General Counsel | |
HOTUNG INVESTMENT HOLDINGS LIMITED | Financial Conglomerates | Director/Board Member Director/Board Member | |
ADVANCE CREATE CO., LTD. | Insurance Brokers/Services | Director/Board Member | |
Daiwa Securities Co., Ltd.
Daiwa Securities Co., Ltd. Investment Banks/BrokersFinance Daiwa Securities Co., Ltd. engages in the business of financial instruments trading services which includes underwriting securities and its related business. It also provides the online trading, brokerage, purchase and sale of securities and acts as an agent or perform agency functions. The company was founded in 1943 and is headquartered in Tokyo, Japan. | Investment Banks/Brokers | Director of Finance/CFO Corporate Officer/Principal | |
Aoyama Gakuin University | College/University | Undergraduate Degree | |
SAMTY CO. | Real Estate Development | Director/Board Member Director/Board Member | |
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
MONEY PARTNERS GROUP CO.,LTD. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Huitung Investments (BVI) Ltd.
Huitung Investments (BVI) Ltd. Investment ManagersFinance Huitung Investments (BVI) Ltd invests in companies located in Greater China, primarily in Taiwan, China and the US. The fund focuses on companies operating in the fields of IC design & semiconductors, optoelectronics, electronic components, wireless communications, new materials, software, internet, IT services and biochemistry. It provides financing for early, expansion and later stage capital requirements. It invests both in public and private companies. | Investment Managers | Director/Board Member | |
Hotung Venture Capital Corp.
Hotung Venture Capital Corp. Investment ManagersFinance Hotung Venture Capital Corp invests in companies located in Greater China, primarily in Taiwan, China and the US. The fund focuses on companies operating in the fields of IC design & semiconductors, optoelectronics, electronic components, wireless communications, new materials, software, internet, IT services, retail, e-business, and biochemistry. It provides financing for early, expansion and later stage capital requirements. It invests in both public and private companies. | Investment Managers | Director/Board Member | |
TMRC Co. Ltd.
TMRC Co. Ltd. Medical/Nursing ServicesHealth Services TMRC Co. Ltd. provides contract research and manufactures medicines. It develops anti-cancer products and those for cancer associated disorders. The company was founded by Hisao Ekimoto in January 2002 and is headquartered in Tokyo, Japan. | Medical/Nursing Services | Director/Board Member | |
RIBOMIC INC. | Pharmaceuticals: Major | Director/Board Member | |
Cardio, Inc. | Director/Board Member | ||
Nagoya City University | College/University | Undergraduate Degree | |
RAQUALIA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
DCI Partners KK
DCI Partners KK Investment ManagersFinance DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan. | Investment Managers | Comptroller/Controller/Auditor | |
SPinno Co., Ltd.
SPinno Co., Ltd. Information Technology ServicesTechnology Services SPinno Co., Ltd. provides cloud platform, promotional marketing and digital marketing services. The company was founded in April 2009 and is headquartered in Tokyo, Japan. | Information Technology Services | Director/Board Member | |
Daiwa Fund Consulting Co. Ltd.
Daiwa Fund Consulting Co. Ltd. Investment ManagersFinance Part of Daiwa Securities Group, Inc., Daiwa Fund Consulting Co. Ltd. is a Japanese company that provides asset management, discretionary investment, and investment advisory services. The company is based in Chiyoda-ku, Japan. The company was founded in 2006. The CEO is Tetsuo Akuzawa. | Investment Managers | Director/Board Member Director/Board Member | |
Daiwa Corporate Investment Asia Ltd.
Daiwa Corporate Investment Asia Ltd. Investment Banks/BrokersFinance Part of Daiwa Securities Group, Inc., Daiwa Corporate Investment Asia Ltd. is a Chinese company that provides securities brokerage, investment banking, and asset management services. The company is based in Hong Kong, Hong Kong. | Investment Banks/Brokers | Director/Board Member |
Statistiche
Distribuzione geografica
Giappone | 16 |
Taiwan | 2 |
Stati Uniti | 2 |
Hong Kong | 2 |
Settori
Finance | 13 |
Health Technology | 4 |
Consumer Services | 3 |
Health Services | 2 |
Technology Services | 2 |
Posizioni
Director/Board Member | 25 |
Corporate Officer/Principal | 16 |
Private Equity Investor | 12 |
Independent Dir/Board Member | 3 |
Undergraduate Degree | 2 |
Contatti più connessi
- Borsa valori
- Insiders
- Naoyuki Miura
- Connessioni Società